Lymphoma: The Added Value of Radiomics, Volumes and Global Disease Assessment.

ABSTRACT

Lymphoma represents a condition that holds promise for cure with existing treatment modalities; nonetheless, the primary clinical obstacle lies in advancing therapeutic outcomes by pinpointing high-risk individuals who are unlikely to respond favorably to standard therapy. In this article, the authors will delineate the significant strides achieved in the lymphoma field, with a particular emphasis on the 3 prevalent subtypes Hodgkin lymphoma, diffuse large B-cell lymphomas, and follicular lymphoma.